![Mats Lindskog](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mats Lindskog
Director/Board Member at
ONCOZENGE AB
Profile
Mats Lindskog currently works at OncoZenge AB, as Independent Director from 2025.
Mr. Lindskog also formerly worked at ACAP Invest AB, as Chief Executive Officer in 2012.
Mr. Lindskog received his graduate degree and doctorate degree from Royal Institute of Technology and undergraduate degree from Blekinge Tekniska Högskola.
Mats Lindskog active positions
| Companies | Position | Start |
|---|---|---|
| ONCOZENGE AB | Director/Board Member | 2024-12-31 |
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Corporate Officer/Principal | - |
Former positions of Mats Lindskog
| Companies | Position | End |
|---|---|---|
| WNTRESEARCH AB | Director/Board Member | - |
| ACAP INVEST AB | Chief Executive Officer | - |
Training of Mats Lindskog
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
ACAP Invest AB
 ACAP Invest AB Investment Trusts/Mutual FundsMiscellaneous Provides investment services | Miscellaneous |
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wntresearch AB
 Wntresearch AB Pharmaceuticals: OtherHealth Technology Develops novel anti-metastatic therapies based synthetic peptides | Health Technology |
Blekinge Tekniska Högskola
 Blekinge Tekniska Högskola Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Health Technology |
OncoZenge AB
 OncoZenge AB Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that develops products for supportive care of cancer patients | Health Technology |
- Stock Market
- Insiders
- Mats Lindskog
